Colorectal Cancer Trial, Recruiting NCT04999007 Sponsor: Jichao Qin Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT04999007
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years and younger than 85 years old.
  • People who have been diagnosed with a type of rectal cancer called rectal adenocarcinoma, confirmed by a biopsy or tissue test before surgery.
  • People for whom surgeons plan a specific type of rectal surgery, called total mesorectal excision, with the goal of fully removing the cancer.
  • People whose overall health before surgery falls within a standard medical fitness rating known as ASA class I, II, or III — meaning generally healthy through to having some serious but manageable health conditions (confirm with trial site).
  • People who are able and willing to provide written agreement to take part in the trial.

Who may not be able to join:

  • Women who are pregnant or currently breastfeeding.
  • People who have a severe mental health condition or a significant difficulty with language or communication.
  • People whose surgery involves a procedure called a Hartmann procedure or the creation of a colostomy (a surgical opening on the abdomen for waste removal).
  • People whose surgery is interrupted or paused for more than 30 minutes for any reason.
  • People who have a cancer affecting another organ in addition to the rectal cancer.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jichao Qin, MD, Huazhong University of Science and Technology

Phone: +86-27-83665316

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jichao Qin
Registry
ClinicalTrials.gov
Start date
2 September 2021
Est. completion
1 September 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The rate of temporary ileostomy.; The morbidity of anastomotic leakage.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov